Product Code: TMRGL41996
The report provides revenue of the global collagen dressings market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global collagen dressings market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the collagen dressings market.
The report delves into the competitive landscape of the global collagen dressings market. Key players operating in the global collagen dressings market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global collagen dressings market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Collagen Dressings Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Dressings Type Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Collagen Dressings Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Key Industry Events
- 5.2. Regulatory Scenario by Region/globally
- 5.3. COVID-19 Impact Analysis
6. Global Collagen Dressings Market Analysis and Forecast, by Dressings Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Dressings Type, 2017-2031
- 6.3.1. Antimicrobial Collagen Dressings
- 6.3.2. Alginate Collagen Dressings
- 6.3.3. Hydrogel Collagen Dressings
- 6.3.4. Native Collagen Dressings
- 6.3.5. Others
- 6.4. Market Attractiveness Analysis, by Dressings Type
7. Global Collagen Dressings Market Analysis and Forecast, by Source
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Source, 2017-2031
- 7.3.1. Bovine
- 7.3.2. Porcine
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis, by Source
8. Global Collagen Dressings Market Analysis and Forecast, by Application
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Applications, 2017-2031
- 8.3.1. Acute Wounds
- 8.3.1.1. Surgical Wounds
- 8.3.1.2. Burns
- 8.3.2. Chronic Wounds
- 8.3.2.1. Ulcers and Ischemic
- 8.3.2.1.1. Diabetic Foot Ulcers
- 8.3.2.1.2. Pressure Ulcers
- 8.3.2.1.3. Others
- 8.3.2.2. Infectious Wounds
- 8.4. Market Attractiveness Analysis, by Application
9. Global Collagen Dressings Market Analysis and Forecast, by End-user
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Clinics
- 9.3.3. Ambulatory Surgical Centers
- 9.3.4. Others
- 9.4. Market Attractiveness Analysis, by End-user
10. Global Collagen Dressings Market Analysis and Forecast, by Region
- 10.1. Key Findings
- 10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness Analysis, by Region
11. North America Collagen Dressings Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Dressings Type, 2017-2031
- 11.2.1. Antimicrobial Collagen Dressings
- 11.2.2. Alginate Collagen Dressings
- 11.2.3. Hydrogel Collagen Dressings
- 11.2.4. Native Collagen Dressings
- 11.2.5. Others
- 11.3. Market Value Forecast, by Source, 2017-2031
- 11.3.1. Bovine
- 11.3.2. Porcine
- 11.3.3. Others
- 11.4. Market Value Forecast, by Applications, 2017-2031
- 11.4.1. Acute Wounds
- 11.4.1.1. Surgical Wounds
- 11.4.1.2. Burns
- 11.4.2. Chronic Wounds
- 11.4.2.1. Ulcers and Ischemic
- 11.4.2.1.1. Diabetic Foot Ulcers
- 11.4.2.1.2. Pressure Ulcers
- 11.4.2.1.3. Others
- 11.4.2.2. Infectious Wounds
- 11.5. Market Value Forecast, by End-user, 2017-2031
- 11.5.1. Hospitals
- 11.5.2. Clinics
- 11.5.3. Ambulatory Surgical Centers
- 11.5.4. Others
- 11.6. Market Value Forecast, by Country, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Dressings Type
- 11.7.2. By Source
- 11.7.3. By Application
- 11.7.4. By End-user
- 11.7.5. By Country
12. Europe Collagen Dressings Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Dressings Type, 2017-2031
- 12.2.1. Antimicrobial Collagen Dressings
- 12.2.2. Alginate Collagen Dressings
- 12.2.3. Hydrogel Collagen Dressings
- 12.2.4. Native Collagen Dressings
- 12.2.5. Others
- 12.3. Market Value Forecast, by Source, 2017-2031
- 12.3.1. Bovine
- 12.3.2. Porcine
- 12.3.3. Others
- 12.4. Market Value Forecast, by Applications, 2017-2031
- 12.4.1. Acute Wounds
- 12.4.1.1. Surgical Wounds
- 12.4.1.2. Burns
- 12.4.2. Chronic Wounds
- 12.4.2.1. Ulcers and Ischemic
- 12.4.2.1.1. Diabetic Foot Ulcers
- 12.4.2.1.2. Pressure Ulcers
- 12.4.2.1.3. Others
- 12.4.2.2. Infectious Wounds
- 12.5. Market Value Forecast, by End-user, 2017-2031
- 12.5.1. Hospitals
- 12.5.2. Clinics
- 12.5.3. Ambulatory Surgical Centers
- 12.5.4. Others
- 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Dressings Type
- 12.7.2. By Source
- 12.7.3. By Application
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region
13. Asia Pacific Collagen Dressings Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Dressings Type, 2017-2031
- 13.2.1. Antimicrobial Collagen Dressings
- 13.2.2. Alginate Collagen Dressings
- 13.2.3. Hydrogel Collagen Dressings
- 13.2.4. Native Collagen Dressings
- 13.2.5. Others
- 13.3. Market Value Forecast, by Source, 2017-2031
- 13.3.1. Bovine
- 13.3.2. Porcine
- 13.3.3. Others
- 13.4. Market Value Forecast, by Applications, 2017-2031
- 13.4.1. Acute Wounds
- 13.4.1.1. Surgical Wounds
- 13.4.1.2. Burns
- 13.4.2. Chronic Wounds
- 13.4.2.1. Ulcers and Ischemic
- 13.4.2.1.1. Diabetic Foot Ulcers
- 13.4.2.1.2. Pressure Ulcers
- 13.4.2.1.3. Others
- 13.4.2.2. Infectious Wounds
- 13.5. Market Value Forecast, by End-user, 2017-2031
- 13.5.1. Hospitals
- 13.5.2. Clinics
- 13.5.3. Ambulatory Surgical Centers
- 13.5.4. Others
- 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Dressings Type
- 13.7.2. By Source
- 13.7.3. By Application
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region
14. Latin America Collagen Dressings Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Dressings Type, 2017-2031
- 14.2.1. Antimicrobial Collagen Dressings
- 14.2.2. Alginate Collagen Dressings
- 14.2.3. Hydrogel Collagen Dressings
- 14.2.4. Native Collagen Dressings
- 14.2.5. Others
- 14.3. Market Value Forecast, by Source, 2017-2031
- 14.3.1. Bovine
- 14.3.2. Porcine
- 14.3.3. Others
- 14.4. Market Value Forecast, by Applications, 2017-2031
- 14.4.1. Acute Wounds
- 14.4.1.1. Surgical Wounds
- 14.4.1.2. Burns
- 14.4.2. Chronic Wounds
- 14.4.2.1. Ulcers and Ischemic
- 14.4.2.1.1. Diabetic Foot Ulcers
- 14.4.2.1.2. Pressure Ulcers
- 14.4.2.1.3. Others
- 14.4.2.2. Infectious Wounds
- 14.5. Market Value Forecast, by End-user, 2017-2031
- 14.5.1. Hospitals
- 14.5.2. Clinics
- 14.5.3. Ambulatory Surgical Centers
- 14.5.4. Others
- 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Dressings Type
- 14.7.2. By Source
- 14.7.3. By Application
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region
15. Middle East & Africa Collagen Dressings Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Dressings Type, 2017-2031
- 15.2.1. Antimicrobial Collagen Dressings
- 15.2.2. Alginate Collagen Dressings
- 15.2.3. Hydrogel Collagen Dressings
- 15.2.4. Native Collagen Dressings
- 15.2.5. Others
- 15.3. Market Value Forecast, by Source, 2017-2031
- 15.3.1. Bovine
- 15.3.2. Porcine
- 15.3.3. Others
- 15.4. Market Value Forecast, by Applications, 2017-2031
- 15.4.1. Acute Wounds
- 15.4.1.1. Surgical Wounds
- 15.4.1.2. Burns
- 15.4.2. Chronic Wounds
- 15.4.2.1. Ulcers and Ischemic
- 15.4.2.1.1. Diabetic Foot Ulcers
- 15.4.2.1.2. Pressure Ulcers
- 15.4.2.1.3. Others
- 15.4.2.2. Infectious Wounds
- 15.5. Market Value Forecast, by End-user, 2017-2031
- 15.5.1. Hospitals
- 15.5.2. Clinics
- 15.5.3. Ambulatory Surgical Centers
- 15.5.4. Others
- 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. By Dressings Type
- 15.7.2. By Source
- 15.7.3. By Application
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (by tier and size of companies)
- 16.2. Market Share Analysis, by Company, 2021
- 16.3. Company Profiles
- 16.3.1. 3M
- 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.1.2. Company Financials
- 16.3.1.3. Growth Strategies
- 16.3.1.4. SWOT Analysis
- 16.3.2. Smith & Nephew
- 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.2.2. Company Financials
- 16.3.2.3. Growth Strategies
- 16.3.2.4. SWOT Analysis
- 16.3.3. Integra Lifesciences Corporation
- 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.3.2. Company Financials
- 16.3.3.3. Growth Strategies
- 16.3.3.4. SWOT Analysis
- 16.3.4. Coloplast Corporation.
- 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.4.2. Company Financials
- 16.3.4.3. SWOT Analysis
- 16.3.5. Organogenesis, Inc.
- 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.5.2. Company Financials
- 16.3.5.3. Growth Strategies
- 16.3.5.4. SWOT Analysis
- 16.3.6. Hollister Incorporated
- 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.6.2. Growth Strategies
- 16.3.6.3. SWOT Analysis
- 16.3.7. BSN Medical
- 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.7.2. SWOT Analysis
- 16.3.8. Angelini S.p.a.
- 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.8.2. Growth Strategies
- 16.3.8.3. SWOT Analysis
- 16.3.9. Medline Industries, Inc.
- 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.9.2. Growth Strategies
- 16.3.9.3. SWOT Analysis
- 16.3.10. DermaRite Industries, LLC
- 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.10.2. SWOT Analysis
- 16.3.11. Covalon Technologies Ltd
- 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.11.2. SWOT Analysis
- 16.3.12. Human BioSciences
- 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.12.2. SWOT Analysis
- 16.3.13. Johnson & Johnson Services, Inc.
- 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.13.2. Company Financials
- 16.3.13.3. Growth Strategies
- 16.3.13.4. SWOT Analysis